Member Sign In

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

On the other hand, Pfizer is exploring strategic alternatives to possibly bid good-bye to its Consumer Healthcare segment. A sale or spin-off of its consumer-health unit is expected next year. Pfizer's consumer sales have been essentially “flat for the past three years.”

This clearly explains why Pfizer intends to concentrate on the more promising, innovative pharmaceutical unit and separate it from Consumer Healthcare. The move also signifies the likely introduction of more deal-making, as per Wall Street Journal. However, the company also kept open chances of retaining the business.

Inside Spin-offs

Sometimes businesses form another autonomous entity from an existing business/division, when they believe that the separated line would add more value as an independent company. In such situations, the parent can focus on its core business management while the new entity can focus on its relative different goals.

How Profitable Spin-offs are to Investors?

According to Cantor Fitzgerald, “spinoffs completed between 2009 and 2013 outperformed the S&P 500 in their first year of trading by an average of more than 17 percent.” As per an article published on benzinga, spun-off entities have been performing better than parent companies lately.

PayPal (PYPL - Free Report) (up about 114%) generated higher gains than parent eBay (EBAY - Free Report) (up about 56%) in the last two years (post spin-off). WhiteWave Foods Co gained about 67.8% in the last three years against an 11.2% decline in Dean Foods Co (DF - Free Report) . WhiteWave Foods was spun off in May 2013. Abbot Laboratories (ABT - Free Report) cut ties with part of its business and formed a new company called AbbVie (ABBV - Free Report) in Jan 2013. ABBV was up 85% while ABT gained 41% in the last three years (as of Oct 12, 2017).

What’s Behind the Recent Surge in Spin-Off

A Chicago-based partner at The Boston Consulting Group recently commented that in a bull market, which we are witnessing currently, equities are overvalued. This makes materialization of mergers and acquisitions difficult. Instead, high valuations better justify “spinning off assets or divesting assets." If this logic holds good, we are likely to see more such actions in the coming days (read: 4 Bargain ETFs in a Pricey Market).

Notably, the United States saw 88 completed spinoffs in 1999, which fell to 80 in 2000, when the dot-com bubble burst. The number further declined to 55 in 2001. The number of actions again rose from 24 in 2007 to 30 in 2008, before sliding to 17 in 2009 when the financial crisis kicked in, as per the data provided by Dealogic, quoted on CNBC. The momentum again gained momentum in 2015 by value, though 2016 and 2017 have been subdued.

ETFs to Play

There are always ways to play such corporate actions. Below we highlight two spin-off ETFs in detail. These ETFs can get further boost from Honeywell and Pfizer’s announcements.

The 95-stock fund follows the Horizon Kinetics Global Spin-Off Index, which is a rules-based, equal-weighted index intended to track the performance of listed, publicly held spin-offs that are domiciled and trade in the U.S. or developed markets of Western Europe and Asia. The net expense ratio of the fund is 0.55%. United States accounts for about 78.8% of the fund. Gannett Co (1.2%), Time Inc. (1.1%) and Timkensteel (1.1%) are top three stocks of the fund.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>

Resources

Client Support

Follow Us

Zacks Research is Reported On:

Yahoo

MSN

Marketwatch

Nasdaq

Forbes

Investors.com

Morningstar

Copyright 2017 Zacks Investment Research

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +25% per year. These returns cover a period from 1988-2016 and were examined and attested by Baker Tilly Virchow Krause, LLP, an independent accounting firm. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zack Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.

Visit performance for information about the performance numbers displayed above.